{
  "content": "Last updated: June 22, 2025 â€¢ View editorial policy\nFrom the Guidelines\nThe recommended initial treatment for rate control in atrial fibrillation is a beta-blocker, diltiazem, verapamil, or digoxin, depending on the patient's left ventricular ejection fraction (LVEF) and other clinical factors, as stated in the 2024 ESC guidelines 1. The choice of initial treatment depends on the patient's LVEF, with beta-blockers, diltiazem, verapamil, or digoxin recommended for patients with LVEF >40% 1.",
  "source": "https://www.droracle.ai/articles/176641/rate-control",
  "chunk_id": "03782f3e-e85f-4032-8964-8c6fd98049bd",
  "similarity_score": 0.4410954713821411,
  "query": "atrial fibrillation guidelines ESC AHA CCS amiodarone beta-blockers recommendations clinical practice first-line therapy",
  "rank": 2,
  "title": "What is the recommended initial treatment for rate control in atrial fibrillation?",
  "authors": "Dr.Oracle Medical Advisory Board & Editors",
  "year": "2025",
  "journal": "Not available",
  "reference": "Dr.Oracle Medical Advisory Board & Editors. (2025). What is the recommended initial treatment for rate control in atrial fibrillation? Retrieved June 22, 2025, from Dr.Oracle Medical Advisory Board website.",
  "doi": "Not available",
  "chunk_index": 2,
  "total_chunks": 14,
  "retrieved_at": "2025-07-24T21:58:06.270276"
}